Related references
Note: Only part of the references are listed.Capitonnage seems better in childhood pulmonary hydatid cyst surgery
Amine Ksia et al.
JOURNAL OF PEDIATRIC SURGERY (2020)
Diagnostic value of soluble programmed cell death protein-1 in type-1 autoimmune hepatitis in Egyptian children
Ola G. Behairy et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2020)
The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma
Boyang Chang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Soluble programmed death-1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B
Liang Zhou et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Soluble programmed death-ligand 1 are highly expressed in peripheral T-cell lymphoma: a biomarker for prognosis
Haorui Shen et al.
HEMATOLOGY (2019)
PDL-1 Blockade Prevents T Cell Exhaustion, Inhibits Autophagy, and Promotes Clearance of Leishmania donovani
Samar Habib et al.
INFECTION AND IMMUNITY (2018)
Increased levels of soluble co-stimulatory molecule PD-L1 (B7-H1) in the plasma of viraemic HIV-1+ individuals
A. Leon-Flores et al.
IMMUNOLOGY LETTERS (2018)
Evaluation of the recombinant antigens B2t and 2B2t, compared with hydatid fluid, in IgG-ELISA and immunostrips for the diagnosis and follow up of CE patients
Ana Hernandez-Gonzalez et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Immunotherapy of alveolar echinococcosis via PD-1/PD-L1 immune checkpoint blockade in mice
Junhua Wang et al.
PARASITE IMMUNOLOGY (2018)
Soluble immune checkpoints in cancer: production, function and biological significance
Daqian Gu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Immune checkpoint blockade in infectious diseases
Michelle N. Wykes et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Follow-up of surgically treated patients with cystic echinococcosis: can novel recombinant antigens compete with imaging? Analysis of a patient cohort
Marija Stojkovic et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2017)
Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer
Xinxin Zhu et al.
ONCOTARGET (2017)
Role of soluble programmed death-1 (sPD-1) and sPD- ligand 1 in patients with cystic echinococcosis
Yanhua Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Genetic relationship between the Echinococcus granulosus sensu stricto cysts located in lung and liver of hosts
Myriam Oudni-M'rad et al.
INFECTION GENETICS AND EVOLUTION (2016)
The intermediate host immune response in cystic echinococcosis
F. Tamarozzi et al.
PARASITE IMMUNOLOGY (2016)
The PD1:PD-L1/2 Pathway from Discovery to Clinical implementation
Kankana Bardhan et al.
FRONTIERS IN IMMUNOLOGY (2016)
Upregulation of PD-1 on CD4+CD25+T cells is associated with immunosuppression in liver of mice infected with Echinococcus multilocularis
Xiaolin La et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Echinococcus granulosus: Epidemiology and state-of-the-art of diagnostics in animals
Philip Craig et al.
VETERINARY PARASITOLOGY (2015)
Serological Diagnosis and Follow-Up of Human Cystic Echinococcosis: A New Hope for the Future?
Raul Manzano-Roman et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Echinococcus P29 Antigen: Molecular Characterization and Implication on Post-Surgery Follow-Up of CE Patients Infected with Different Species of the Echinococcus granulosus Complex
Ghalia Boubaker et al.
PLOS ONE (2014)
Long-term Sonographic and Serological Follow-up of Inactive Echinococcal Cysts of the Liver: Hints for a Watch-and-Wait Approach
Luca Piccoli et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
A Systematic Review of the Literature on Cystic Echinococcosis Frequency Worldwide and Its Associated Clinical Manifestations
Christine M. Budke et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Improved Serodiagnosis of Cystic Echinococcosis Using the New Recombinant 2B2t Antigen
Ana Hernandez-Gonzalez et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade
Rajarshi Bhadra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans
Enrico Brunetti et al.
ACTA TROPICA (2010)
The Global Burden of Alveolar Echinococcosis
Paul R. Torgerson et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Isolation and molecular characterization of recombinant Echinococcus granulosus P29 protein (recP29) and its assessment for the post-surgical serological follow-up of human cystic echinococcosis in young patients
Nadia Ben Nouir et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2009)
Metabolic viability assessment of cystic echinococcosis using high-field 1H MRS of cyst contents
Waldemar Hosch et al.
NMR IN BIOMEDICINE (2008)
Usefulness of four different Echinococcus granulosus recombinant antigens for serodiagnosis of unilocular hydatid disease (UHD) and postsurgical follow-up of patients treated for UHD
Ana Hernandez-Gonzalez et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Postoperative recurrence in hepatic hydatid disease
Metin Kapan et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2006)
Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis
LI Terrazas et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2005)
Molecular characterization of P-29, a metacestode-specific component of Echinococcus granulosus which is immunologically related to, but distinct from, antigen 5
G González et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)